Showing results (1131-1140 of 1,200) with videos related to

Sort By:
Pageof 120
The Lancet. Oncology|July 24, 2019
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trialSilvia Stacchiotti, Stefano Ferrari, Andres Redondo, et al.
Plos One|August 4, 2017
Additional value of screening for minor genes and copy number variants in hypertrophic cardiomyopathyIrene Mademont-Soler, Jesus Mates, Raquel Yotti, et al.
Cell|April 15, 2021
Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasionEster Gangoso, Benjamin Southgate, Leanne Bradley, et al.
Neuro-Oncology|April 25, 2020
A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01)Carmen Balana, Maria Angeles Vaz, Juan Manuel Sepúlveda, et al.
Journal of Hepatology|March 2, 2010
High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirinStefan Wirth, Carmen Ribes-Koninckx, Maria Angeles Calzado, et al.
Haematologica|April 26, 2012
Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosisJulien Broseus, Lourdes Florensa, Esther Zipperer, et al.
Acta Neuropathologica Communications|October 17, 2018
Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer's diseaseKelly Ceyzériat, Lucile Ben Haim, Audrey Denizot, et al.
Brain : a Journal of Neurology|March 17, 2022
Reactive astrocytes promote proteostasis in Huntington's disease through the JAK2-STAT3 pathwayLaurene Abjean, Lucile Ben Haim, Miriam Riquelme-Perez, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 10, 2025
Safety and immunogenicity of a homologous booster dose of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: 12 months follow-up result of an open-label, nonrandomized extension of a phase 1/2 trialJoon Young Song, Won Suk Choi, Jung Yeon Heo, et al.
Vaccine|February 22, 2021
Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trialFederico Martinón-Torres, Scott A Halperin, Terry Nolan, et al.
Pageof 120